83 FR 27627 - Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest

INTERNATIONAL TRADE COMMISSION

Federal Register Volume 83, Issue 114 (June 13, 2018)

Page Range		27627-27628
FR Document		2018-12651

Notice is hereby given that the U.S. International Trade Commission has received a complaint entitled Certain Convertible Sofas and Components Thereof, DN 3321; the Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure.

Federal Register, Volume 83 Issue 114 (Wednesday, June 13, 2018)

[Federal Register Volume 83, Number 114 (Wednesday, June 13, 2018)]
[Notices]
[Pages 27627-27628]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-12651]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION


Notice of Receipt of Complaint; Solicitation of Comments Relating 
to the Public Interest

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has received a complaint entitled Certain Convertible Sofas 
and Components Thereof, DN 3321; the Commission is soliciting comments 
on any public interest issues raised by the complaint or complainant's 
filing pursuant to the Commission's Rules of Practice and Procedure.

FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Secretary to the 
Commission, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 205-2000. The public version of 
the complaint can be accessed on the Commission's Electronic Document 
Information System (EDIS) at https://edis.usitc.gov, and will be 
available for inspection during official business hours (8:45 a.m. to 
5:15 p.m.) in the Office of the Secretary, U.S. International Trade 
Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-
2000.
    General information concerning the Commission may also be obtained 
by accessing its internet server at United States International Trade 
Commission (USITC) at https://www.usitc.gov. The public record for this 
investigation may be viewed on the Commission's Electronic Document 
Information System (EDIS) at https://edis.usitc.gov. Hearing-impaired 
persons are advised that information on this matter can be obtained by 
contacting the Commission's TDD terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: The Commission has received a complaint and 
a submission pursuant to Sec.  210.8(b) of the Commission's Rules of 
Practice and Procedure filed on behalf of Sauder Manufacturing Company 
on June 7, 2018. The complaint alleges violations of section 337 of the 
Tariff Act of 1930 (19 U.S.C. 1337) in the importation into the United 
States, the sale for importation, and the sale within the United States 
after importation of certain convertible sofas and components thereof. 
The complaint names as a respondent: Krug, Inc. of Canada. The 
complainant requests that the Commission issue a limited exclusion 
order, a cease and desist order, and impose a bond upon respondents' 
alleged infringing articles during the 60-day Presidential review 
period pursuant to 19 U.S.C. 1337(j).
    Proposed respondents, other interested parties, and members of the 
public are invited to file comments, not to exceed five (5) pages in 
length, inclusive of attachments, on any public interest issues raised 
by the complaint or Sec.  210.8(b) filing. Comments should address 
whether issuance of the relief specifically requested by the 
complainant in this investigation would affect the public health and 
welfare in the United States, competitive conditions in the United 
States economy, the production of like or directly competitive articles 
in the United States, or United States consumers.
    In particular, the Commission is interested in comments that:
    (i) Explain how the articles potentially subject to the requested 
remedial orders are used in the United States;
    (ii) identify any public health, safety, or welfare concerns in the 
United States relating to the requested remedial orders;
    (iii) identify like or directly competitive articles that 
complainant, its licensees, or third parties make in the United States 
which could replace the subject articles if they were to be excluded;
    (iv) indicate whether complainant, complainant's licensees, and/or 
third party suppliers have the capacity to replace the volume of 
articles potentially subject to the requested exclusion order and/or a 
cease and desist order within a commercially reasonable time; and
    (v) explain how the requested remedial orders would impact United 
States consumers.
    Written submissions must be filed no later than by close of 
business, eight calendar days after the date of publication of this 
notice in the Federal Register. There will be further opportunities for 
comment on the public interest after the issuance of any final initial 
determination in this investigation.
    Persons filing written submissions must file the original document 
electronically on or before the deadlines stated above and submit 8 
true paper copies to the Office of the Secretary by noon the next day 
pursuant to Sec.  210.4(f) of the Commission's Rules of Practice and 
Procedure (19 CFR 210.4(f)). Submissions should refer to the docket 
number (``Docket No. 3321) in a prominent place on the cover page and/
or the first page. (See Handbook for Electonic Filing Procedures, 
Electronic Filing Procedures).\1\ Persons with questions regarding 
filing should contact the Secretary (202-205-2000).
---------------------------------------------------------------------------

    \1\ Handbook for Electronic Filing Procedures: https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf.
---------------------------------------------------------------------------

    Any person desiring to submit a document to the Commission in 
confidence must request confidential treatment. All such requests 
should be directed to the Secretary to the Commission and must include 
a full

[[Page 27628]]

statement of the reasons why the Commission should grant such 
treatment. See 19 CFR 201.6. Documents for which confidential treatment 
by the Commission is properly sought will be treated accordingly. All 
such requests should be directed to the Secretary to the Commission and 
must include a full statement of the reasons why the Commission should 
grant such treatment. See 19 CFR 201.6. Documents for which 
confidential treatment by the Commission is properly sought will be 
treated accordingly. All information, including confidential business 
information and documents for which confidential treatment is properly 
sought, submitted to the Commission for purposes of this Investigation 
may be disclosed to and used: (i) By the Commission, its employees and 
Offices, and contract personnel (a) for developing or maintaining the 
records of this or a related proceeding, or (b) in internal 
investigations, audits, reviews, and evaluations relating to the 
programs, personnel, and operations of the Commission including under 5 
U.S.C. Appendix 3; or (ii) by U.S. government employees and contract 
personnel,\2\ solely for cybersecurity purposes. All nonconfidential 
written submissions will be available for public inspection at the 
Office of the Secretary and on EDIS.\3\
---------------------------------------------------------------------------

    \2\ All contract personnel will sign appropriate nondisclosure 
agreements.
    \3\ Electronic Document Information System (EDIS): https://edis.usitc.gov.
---------------------------------------------------------------------------

    This action is taken under the authority of section 337 of the 
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of Sec. Sec.  
201.10 and 210.8(c) of the Commission's Rules of Practice and Procedure 
(19 CFR 201.10, 210.8(c)).

    By order of the Commission.

    Issued: June 7, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018-12651 Filed 6-12-18; 8:45 am]
 BILLING CODE 7020-02-P

27628 Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices

statement of the reasons why the DATES: Registered bulk manufacturers of Control Division, Drug Enforcement
Commission should grant such the affected basic classes, and Administration (hereinafter, DEA or
treatment. See 19 CFR 201.6. Documents applicants therefore, may file written Government), issued an Order to Show
for which confidential treatment by the comments on or objections to the Cause to Gazelle A. Craig, D.O.
Commission is properly sought will be issuance of the proposed registration on (hereinafter, Respondent), of Houston,
treated accordingly. All such requests or before August 13, 2018. Texas. GX 2 (Order to Show Cause). The
should be directed to the Secretary to ADDRESSES: Written comments should Show Cause Order proposed the
the Commission and must include a full be sent to: Drug Enforcement revocation of Respondent’s Certificate of
statement of the reasons why the Administration, Attention: DEA Federal Registration on the ground that she does
Commission should grant such Register Representative/DRW, 8701 ‘‘not have authority to handle controlled
treatment. See 19 CFR 201.6. Documents Morrissette Drive, Springfield, Virginia substances in the State of Texas, the
for which confidential treatment by the 22152. [S]tate in which . . . [she is] registered
Commission is properly sought will be
SUPPLEMENTARY INFORMATION: The with the DEA.’’ Id. at 1 (citing 21 U.S.C.
treated accordingly. All information,
Attorney General has delegated his 823(f) and 824(a)(3)).
including confidential business authority under the Controlled
information and documents for which As to the Agency’s jurisdiction, the
Substances Act to the Administrator of
confidential treatment is properly Show Cause Order alleged that
the Drug Enforcement Administration
sought, submitted to the Commission for (DEA), 28 CFR 0.100(b). Authority to Respondent holds DEA Certificate of
purposes of this Investigation may be exercise all necessary functions with Registration No. FC1384306, which
disclosed to and used: (i) By the respect to the promulgation and authorizes her to dispense controlled
Commission, its employees and Offices, implementation of 21 CFR part 1301, substances in schedules II through V as
and contract personnel (a) for incident to the registration of a practitioner, at the registered address
developing or maintaining the records manufacturers, distributors, dispensers, of Gulfton Community Health Center,
of this or a related proceeding, or (b) in importers, and exporters of controlled 6306 Gulfton St., Suite 101, Houston,
internal investigations, audits, reviews, substances (other than final orders in Texas 77081. Id. The Show Cause Order
and evaluations relating to the connection with suspension, denial, or alleged that this registration expires on
programs, personnel, and operations of revocation of registration) has been August 31, 2018. Id.
the Commission including under 5 delegated to the Assistant Administrator
U.S.C. Appendix 3; or (ii) by U.S. As the substantive ground for the
of the DEA Diversion Control Division proceeding, the Show Cause Order
government employees and contract (‘‘Assistant Administrator’’) pursuant to
personnel,2 solely for cybersecurity alleged that Respondent is ‘‘without
section 7 of 28 CFR part 0, appendix to
purposes. All nonconfidential written authority to handle controlled
subpart R.
submissions will be available for public In accordance with 21 CFR substances in the State of Texas, the
inspection at the Office of the Secretary 1301.33(a), this is notice that on May [S]tate in which . . . [she is] registered
and on EDIS.3 3rd, 2018, Alcami Wisconsin . . . with the DEA.’’ Id. It further
This action is taken under the Corporation, W130 N10497 Washington alleged that, on July 28, 2017, the Texas
authority of section 337 of the Tariff Act Dr., Germantown, WI 53022 applied to Medical Board temporarily suspended
of 1930, as amended (19 U.S.C. 1337), be registered as a bulk manufacturer of Respondent’s medical license and that
and of §§ 201.10 and 210.8(c) of the the following basic classes of controlled the Texas Medical Board order remains
Commission’s Rules of Practice and substances: in effect. Id. The Show Cause Order
Procedure (19 CFR 201.10, 210.8(c)). asserted that Respondent is ‘‘required to
By order of the Commission. Controlled possess authority from a [S]tate in order
Drug code Schedule
substance to obtain or retain a DEA
Issued: June 7, 2018.
Lisa Barton, Thebaine ........... 9333 II Registration. . . . [and c]onsequently,
Secretary to the Commission. Alfentanil ........... 9737 II the DEA must revoke . . . [her
[FR Doc. 2018–12651 Filed 6–12–18; 8:45 am]
registration] based upon [her] lack of
The company plans to provide bulk authority to handle controlled
BILLING CODE 7020–02–P
active pharmaceutical ingredient to substances in the State of Texas.’’ Id. at
support clinical trials. 1–2.
DEPARTMENT OF JUSTICE Dated: June 6, 2018. The Show Cause Order notified
John J. Martin, Respondent of her right to request a
Drug Enforcement Administration Assistant Administrator. hearing on the allegations or to submit
[FR Doc. 2018–12684 Filed 6–12–18; 8:45 am] a written statement while waiving her
[Docket No. DEA–392]
BILLING CODE 4410–09–P right to a hearing, the procedures for
Bulk Manufacturer of Controlled electing each option, and the
Substances Application: Alcami consequences for failing to elect either
Wisconsin Corporation DEPARTMENT OF JUSTICE option. Id. at 2 (citing 21 CFR 1301.43).
The Show Cause Order also notified
ACTION: Notice of application. Drug Enforcement Administration
Respondent of the opportunity to
amozie on DSK3GDR082PROD with NOTICES1

Gazelle A. Craig, D.O.; Decision and submit a Corrective Action Plan. Id. at
2 All contract personnel will sign appropriate Order 2–3 (citing 21 U.S.C. 824(c)(2)(C)).
nondisclosure agreements.
3 Electronic Document Information System On September 20, 2017, the Acting
(EDIS): https://edis.usitc.gov. Assistant Administrator, Diversion

VerDate Sep<11>2014 18:01 Jun 12, 2018 Jkt 244001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\13JNN1.SGM 13JNN1

Document Created: 2018-06-12 23:59:29
Document Modified: 2018-06-12 23:59:29

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		Lisa R. Barton, Secretary to the Commission, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-2000. The public version of the complaint can be accessed on the Commission's Electronic Document Information System (EDIS) at https://edis.usitc.gov, and will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205- 2000.
FR Citation		83 FR 27627